methotrexate-gamma-1,2-dimyristoylphosphatidylethanolamine has been researched along with Disease Models, Animal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amos, N; Goodfellow, RM; Jones, SG; Williams, AS; Williams, BD | 1 |
1 other study(ies) available for methotrexate-gamma-1,2-dimyristoylphosphatidylethanolamine and Disease Models, Animal
| Article | Year |
|---|---|
Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cattle; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Hindlimb; Interleukin-1; Lipopolysaccharides; Liposomes; Macrophages, Peritoneal; Methotrexate; Phosphatidylethanolamines; Rats; Rats, Inbred Lew; Time Factors | 1999 |